| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jasper Therapeutics, Inc. (JSPR) has 11 insiders with recent SEC Form 4 filings, including 6 buys and 4 sells. JSPR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 234.0K | $216.8K | - | |
| Dir | 156.9K | $145.3K | - | |
| COO | 90.0K | $83.4K | - | |
| CFO | 90.0K | $83.4K | - | |
| Other | 90.0K | $83.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | Martell Ron | President And CEO | Buy | 41,000 | $2.43 | $99,630.00 | +123.8% | -24.8% | - | |
| Sep 22, 2025 | Wiggans Thomas G89 | Director | Buy | 41,000 | $2.43 | $99,630.00 | New | -24.8% | - | |
| Sep 22, 2025 | Shizuru Judith Anne | Director | Buy | 41,000 | $2.43 | $99,630.00 | +35.4% | -24.8% | - | |
| Sep 22, 2025 | Lucas Svetlana | Director | Buy | 20,000 | $2.43 | $48,600.00 | New | -24.8% | - | |
| Dec 12, 2024 | Mahal Jeetinder Singh73 | Chief Operating Officer | Sale+OE | 900 | $22.11 | $19,899.00 | -3.5% | -73.7% | -91.4% | |
| Sep 12, 2024 | Mahal Jeetinder Singh73 | Chief Operating Officer | Sale+OE | 900 | $21.23 | $19,103.67 | -3.5% | +4.7% | -88.7% | |
| Jun 12, 2024 | Mahal Jeetinder Singh73 | Chief Operating Officer | Sale+OE | 900 | $24.16 | $21,739.50 | -3.5% | -15.5% | -76.8% | |
| Mar 12, 2024 | Mahal Jeetinder Singh73 | Chief Operating Officer | Sale+OE | 900 | $26.44 | $23,792.22 | -3.5% | -7.9% | -79.3% | |
| Feb 8, 2024 | Velan Capital Investment Management LP | 10% Owner | Buy | 350,000 | $12.95 | $4,532,500.00 | +41.7% | +22.1% | -64.6% | |
| Nov 28, 2023 | Wiggans Thomas G89 | Director | Buy | 10,000 | $0.65 | $6,486.00 | +25.0% | +220.0% | +257.6% |